Stimulant-Related Disorders
DEFINITION
The nonmedical misuse or abuse of, or dependence on, psychostimulants such as:
- Amphetamines were first used as a nasal decongestant and then by the U.S. military to improve alertness in troops. In the 1950s, they gained popularity as weight-loss drugs (e.g., ephedra, ma huang) and became frequently misused medications. They enhance dopamine and norepinephrine activity in the mesocorticolimbic pathway due to effects on monoamine transporters.[1]
- Cocaine is a tropane ester alkaloid found in leaves of the Erythroxylum coca plant that enhances dopamine, norepinephrine, and serotonin activity by blocking presynaptic reuptake. It also activates the corticomesolimbic dopamine reward circuit. [2]Smoked or IV produces effects lasting 15-30 min; snorting and ingested use lasts 1-3 hours.[3]
- Cocaine base, ("crack," "freebase") which can be smoked because it has a relatively low melting point (98ºC) and vaporizes. It is rarely injected because it is relatively insoluble. Onset of action is within seconds.[3]
- Cocaine HCl cannot be efficiently smoked because it melts at 195ºC with substantial loss of the active metabolites. Cocaine salt is readily injected or insufflated ("snorted") through the nose; it is highly water soluble with onset of action in 20-30 minutes.[3]
- Methamphetamine is a psychostimulant derived from amphetamines and increases the release and blocks the reuptake of monoamine neurotransmitters. Starting in the late 1980s, use of methamphetamine has evolved to include a wider range of the population and of the country (used to be localized mostly to CA and OR). Street names include crystal meth, crank, ice, chalk, and Tina.[4]
- Synthetic cathinones (AKA "bath salts") are beta-ketone amphetamine analogs that vary in pharmacologic properties. They are reported to increase energy, empathy, and libido (associated with high-risk sexual behavior)[5]. They emerged as a misused substance in Europe in 2009 and spread to the U.S. in 2010.[6]
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 1, 2025
Citation
Gary, Joseph, and Amy Tao. "Stimulant-Related Disorders." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787103/0/Stimulant_Related_Disorders.
Gary J, Tao A. Stimulant-Related Disorders. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787103/0/Stimulant_Related_Disorders. Accessed October 8, 2025.
Gary, J., & Tao, A. (2025). Stimulant-Related Disorders. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787103/0/Stimulant_Related_Disorders
Gary J, Tao A. Stimulant-Related Disorders [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787103/0/Stimulant_Related_Disorders.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Stimulant-Related Disorders
ID - 787103
A1 - Gary,Joseph,M.D.
AU - Tao,Amy,M.D.
Y1 - 2025/09/01/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787103/0/Stimulant_Related_Disorders
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -